Adaptive Biotechnologies ADPT Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's sales & marketing?
- Adaptive Biotechnologies (ADPT) reported sales & marketing of $26.35M in Q1 2026.
- How has Adaptive Biotechnologies's sales & marketing changed year-over-year?
- Adaptive Biotechnologies's sales & marketing increased by 14.3% year-over-year, from $23.05M to $26.35M.
- What is the long-term trend for Adaptive Biotechnologies's sales & marketing?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's sales & marketing has grown at a -0.2% compound annual growth rate (CAGR), from $95.47M to $94.57M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.